Couldn't find what you looking for?

TRY OUR SEARCH!

Table of Contents

The search continues for treatment for Alzheimer's disease, the most common cause of dementia. An ongoing clinical trial to evaluate the effectiveness and safety of a new drug called T-817MA provides new hope for improving the treatment of the disease.

Elderly individuals comprise a large portion of the population and their risk for developing Alzheimer’s disease significantly increases as they age. The Alzheimer’s Association reports that someone develops Alzheimer’s every minute. More than 5 million Americans are living with Alzheimer’s disease. Two-thirds of patients are women. Studies also show that women are twice more likely to die of Alzheimer’s disease than from breast cancer. In 2013, unpaid care valued to exceed $220 billion was provided by more than 15 million caregivers in more than 17 billion hours of service.

With the burden of disease rapidly increasing in an aging society, expectations for an effective therapy for Alzheimer’s patients are growing.

Aside from treatment of the disease, scientists are also looking into the possibility of finding preventive therapy for Alzheimer’s disease. One trial, called “A4, ″ is going to evaluate the effects of an anti-amyloid treatment in healthy individuals who have an increased risk of developing the disease, based on PET scan findings that show amyloid protein elevations. The drug, called Solanezumab (manufactured by Eli Lilly & Co.), is the first of its kind to be used for the prevention of the disease.

Continue reading after recommendations

  • Science Daily. Patients sought for U.S. nationwide study of drug that may slow Alzheimer's disease. http://www.sciencedaily.com/releases/2014/11/141112202619.htm
  • WebMD. Alzheimer's Disease – Medications. http://www.webmd.com/alzheimers/tc/alzheimers-disease-medications
  • ALZ Forum. T-817MA. http://www.alzforum.org/therapeutics/t-817ma
  • Alzheimer’s News Today. Experimental T-817MA Therapy Currently Being Tested for Mild to Moderate Alzheimer’s Disease. http://alzheimersnewstoday.com/2014/09/12/experimental-t-817ma-therapy-currently-being-tested-for-mild-to-moderate-alzheimers-disease/
  • NIA. Alzheimer's Disease Fact Sheet. http://www.nia.nih.gov/alzheimers/publication/alzheimers-disease-fact-sheet#treatingPhoto courtesy of Basykes via Flickr: www.flickr.com/photos/basykes/7158418
  • Photo courtesy of Carianoff via Flickr: www.flickr.com/photos/carianoff/3427559493
  • www.sciencedaily.com
  • www.webmd.com
  • www.alzforum.org
  • alzheimersnewstoday.com
  • www.nia.nih.gov

Your thoughts on this

User avatar Guest
Captcha